Ns Pharma, Inc.
Clinical trials sponsored by Ns Pharma, Inc., explained in plain language.
-
New drug trial aims to control rare autoimmune disease while cutting steroid dependence
Disease control Recruiting nowThis study is testing whether an experimental drug called NS-229 can help control eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease. The trial will enroll 45 adults who currently take steroid medications, with the goal of achieving disease remission …
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Apr 03, 2026 23:50 UTC
-
New hope for boys with DMD: weekly infusion aims to restore muscle protein
Disease control Recruiting nowThis study is testing a new drug called NS-089/NCNP-02 for boys with Duchenne muscular dystrophy (DMD) caused by a specific genetic error (exon 44). The drug is given as a weekly IV infusion and aims to help muscles produce more of a crucial protein called dystrophin. Researchers…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for boys with DMD: first human trial of potential Muscle-Saving drug begins
Disease control Recruiting nowThis is the first study in humans of a new drug called NS-050/NCNP-03 for boys with Duchenne muscular dystrophy (DMD). The main goals are to check if the weekly injections are safe and to see how the drug moves through the body. Researchers will also measure if the treatment help…
Phase: PHASE1, PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC